DISPENSATION IN COMMUNITY PHARMACY TO PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED WITH BISPHOSPHONATES OR STRONTIUM RANELATE

被引：0
|
作者：
Moranta Ribas, Francesc [1 ]
Llull Vila, Rosa [1 ]
Oliver Oliver, Bartomeu [1 ]
机构：
[1] Farmaceut Comunitarios Islas Baleares, Palma De Mallorca, Illes Balears, Spain
来源：
FARMACEUTICOS COMUNITARIOS | 2011年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：93 / 98
页数：6
相关论文
共 50 条
  • [31] Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis
    Compston, J
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (Suppl 1) : S4 - S6
  • [32] Strontium ranelate - The first dual acting treatment for postmenopausal osteoporosis
    Burlet, Nansa
    Reginster, Jean-Yves
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2006, (443) : 55 - 60
  • [33] TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH STRONTIUM RANELATE: RESULTS AT THREE YEARS
    Bernad Pineda, M.
    Garces Puentes, M. V.
    Martin Mola, E.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 159 - 159
  • [34] Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis
    Juliet Compston
    Osteoporosis International, 2005, 16 : S4 - S6
  • [35] COMPERATIVE ANALYSIS OF THE EFFECTIVENESS OF MONOTHERAPY WITH STRONTIUM RANELATE AND A COMBINATION OF STRONTIUM RANELATE AND ALFACALCIDOL IN WOMEN WITH CONFIRMED POSTMENOPAUSAL OSTEOPOROSIS
    Alikhanova, N. M.
    Ismailov, S. I.
    Abboskhujaeva, L. S.
    Takhirova, T. A.
    Akramova, G. G.
    Shakirova, M. M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S205 - S206
  • [36] Strontium ranelate in the therapy of postmenopausal osteoporosis at first- and pre-treated patients: results of the OLYMP practice study
    Ringe, J. D.
    OSTEOLOGIE, 2010, 19 (02) : 157 - 164
  • [37] Monitoring strontium ranelate therapy in patients with osteoporosis
    Kendler, D. L.
    Adachi, J. D.
    Josse, R. G.
    Slosman, D. O.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (07) : 1101 - 1106
  • [38] Monitoring strontium ranelate therapy in patients with osteoporosis
    D. L. Kendler
    J. D. Adachi
    R. G. Josse
    D. O. Slosman
    Osteoporosis International, 2009, 20 : 1101 - 1106
  • [39] Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis
    Meunier, PJ
    Roux, C
    Ortolani, S
    Badurski, J
    Kaufman, JM
    Spector, T
    Diez-Perez, A
    Seeman, E
    Lemmel, E
    Balogh, A
    Pors-Nielsen, S
    Phenekos, C
    Rizzoli, R
    Slosman, D
    Tupinon-Mathieu, I
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2002, 13
  • [40] The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
    Meunier, PJ
    Roux, C
    Seeman, E
    Ortolani, S
    Badurski, JE
    Spector, TD
    Cannata, J
    Balogh, A
    Lemmel, EM
    Pors-Nielsen, S
    Rizzoli, R
    Genant, HK
    Reginster, JY
    Graham, J
    Ng, KW
    Prince, R
    Prins, J
    Seeman, E
    Wark, J
    Reginster, JY
    Devogelaer, JP
    Kaufman, JM
    Raeman, F
    Ziekenhuis, JP
    Walravens, M
    Pors-Nielsen, S
    Beck-Nielsen, H
    Charles, P
    Sorensen, OH
    Meunier, PJ
    Aquino, JP
    Benhamou, C
    Blotman, F
    Bonidan, O
    Bourgeois, P
    Dehais, J
    Fardellone, P
    Kahan, A
    Kuntz, JL
    Marcelli, C
    Prost, A
    Vellas, B
    Weryha, G
    Lemmel, EM
    Felsenberg, D
    Hensen, J
    Kruse, HP
    Schmidt, W
    Semler, J
    Stucki, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (05): : 459 - 468
12345